Many known oncogenic and tumour-suppressive miRNAs have been shown to be aberrantly expressed in primary NB tumours, with a particular focus on those targeting MYCN [154–156] among other genes implicated in NB pathogenesis [157]. The gene discussed is MYCN; the disease is neuroblastoma.